NEXENTIS TECHNOLOGIES INC. Adjustments to Additional Paid in Capital, Warrant Issued
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Adjustments to Additional Paid in Capital, Warrant Issued of $34.70 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2022-03-31
- NEXENTIS TECHNOLOGIES INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-03-31 was $34.70K.
- NEXENTIS TECHNOLOGIES INC. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $34.70K, a 64.38% decline from fiscal 2019.
- NEXENTIS TECHNOLOGIES INC. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $97.41K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2020-12-31 | $34.70K 10-K · filed 2022-03-31 | |
| 2020-03-31 | $34.70K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $97.41K 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |